INTERNATIONAL PATENT: ASTRAZENECA IRELAND LIMITED FILES APPLICATION FOR "COMBINATION OF A ALDOSTERONE SYNTHASE INHIBITOR (ASI) AND A SODIUM-GLUCOSE CO-TRANSPORTER 2 INHIBITOR (SGLT2I) FOR USE IN METHODS OF REDUCING THE RISK OF CARDIOVASCULAR AND HEART FAILURE EVENTS IN A SUBJECT"

GENEVA, May 10 -- ASTRAZENECA IRELAND LIMITED (College Business & Technology Park,Blanchardstown Road NorthDublin, D15 R925) filed a patent application (PCT/EP2025/081693) for "COMBINATION OF A ALDOSTERONE SYNTHASE INHIBITOR (ASI) AND A SODIUM-GLUCOSE CO-TRANSPORTER 2 INHIBITOR (SGLT2I) FOR USE IN METHODS OF REDUCING THE RISK OF CARDIOVASCULAR AND HEART FAILURE EVENTS IN A SUBJECT" on Nov 03, 2025. With publication no. WO/2026/093586, the details related to the patent application was published on May 07, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): JOHANSON, Per (ASTRAZENECA ABSE-151 85 S...